$NBRV – Nabriva Therapeutics AGThe purpose of this thread is to provide Irregulars with a chronological discussion of $NBRV only.
Nabriva – Home: http://www.nabriva.com/
$NBRV IPO is tentatively September 18, 2015 at 15-17 USD and shall trade on the Nasdaq Global Market. $NBRV’s lead program is BC-3781: http://newdrugapprovals.org/2014/03/31/bc-3781-a-pleuromutilin-by-nabriva-austria-in-phase-2/
My sincere thanks goes to Dr. KSS, Travis, Lynne and the incredible Gummune at stockgumshoe.com. Best2ALL-Ben
This is a discussion topic or guest posting submitted by a Stock Gumshoe reader. The content has not been edited or reviewed by Stock Gumshoe, and any opinions expressed are those of the author alone.
$NBRV reinstated with an Outperform at Leerink. $14 PT HT https://twitter.com/odibro/status/791606157169262592
$NBRV – presentaion at IDWeek16 http://investors.nabriva.com/phoenix.zhtml?c=254099&p=irol-newsArticle&ID=2217345
Nabriva Achieves 60% Randomization Target in LEAP 1 Phase 3 Trial in Community Acquired Bacterial Pneumonia http://investors.nabriva.com/phoenix.zhtml?c=254099&p=irol-newsArticle&ID=2230824
$NBRV – SC 13G/A
HBM HEALTHCARE INVESTMENTS (CAYMAN) LTD. filed this Form SC 13G/A on 10/10/2017 http://investors.nabriva.com/phoenix.zhtml?c=254099&p=IROL-secToc&TOC=aHR0cDovL2FwaS50ZW5rd2l6YXJkLmNvbS9vdXRsaW5lLnhtbD9yZXBvPXRlbmsmaXBhZ2U9MTE4MzQzNDcmc3Vic2lkPTU3&ListAll=1
Would like to hear some feedback on recent developments in this stock, FDA approval and offering